Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure
Clinical trial NCT06327698 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06327698
- Sponsor
- Hunan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2026-05-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.